Formycon AG

Formycon AG
Stock Exchange Xetra Stock Exchange
EPS
EUR0.76
Market Cap
EUR288.33 M
Shares Outstanding
9.42 M
Public Float
9.42 M

Profile

Address
Fraunhoferstraße 15
Munich Bayern (Bavaria) 82152
Germany
Employees -
Website http://formycon.com
Updated 07/08/2019
Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205 which focusoin the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany.

Financials

View All
Created with Highcharts 5.0.14Formycon AGNet Income. Fiscal year is January-December. All values EUR Thousands.7 7677 7678608605775774 0664 0661 5811 5817 0987 09820132014201520162017201802k4k6k8k10k
Created with Highcharts 5.0.14Formycon AGSales/Revenue. Fiscal year is January-December. All values EUR Thousands.27627612 58512 58516 92516 92519 53319 53329 00329 00342 99342 993201320142015201620172018010k20k30k40k50k

Hermann Vogt
Deputy Chairman-Supervisory Board
Stefan Glombitza
Chief Operating Officer